Stories
Don't sit that long - it increases your cancer risk
Sorry, I couldn't resist. This article says that in a study, women who sat more than 6 hours a day were at a higher risk of developing breast cancer, ovarian c...
Don't sit that long - it increases your cancer risk
Sorry, I couldn't resist. This article says that in a study, women who sat more than 6 hours a day were at a higher risk of developing breast cancer, ovarian c...
STORIES
New to Care Across? Sign up to read all comments and join the conversation
News
>
Latest research available at a glance
Improved response to treatment against breast cancer with BRCA mutation
Adding veliparib to carboplatin and paclitaxel chemotherapy improved the overall response rate among patients with locally recurrent or metastatic breast cancer with BRCA1 or BRCA2 mutations.
FDA approves another use of bevacizumab for treating ovarian cancer
The U.S. FDA has approved bevacizumab for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.